ALL
-
2025.07.17
Article/Poster
Academic Paper on eNK Cells in “Stem Cell Research and Therapy” Human iPSC-derived NK cells armed with CCL19, CCR2B, high-affinity CD16, IL-15, and NKG2D complex enhance anti-solid tumor activity
-
2025.04.15
News
R&D Briefing on ARDS (Video), April 9, 2025
-
2025.03.13
Article/Poster
ONE-BRIDGE Trial in ARDS: Peer-Reviewed Publication in Japan
-
2025.07.17
News
Academic Paper on eNK Cells in “Stem Cell Research and Therapy” Human iPSC-derived NK cells armed with CCL19, CCR2B, high-affinity CD16, IL-15, and NKG2D complex enhance anti-solid tumor activity
-
2025.04.15
News
R&D Briefing on ARDS (Video), April 9, 2025
-
2025.03.13
News
ONE-BRIDGE Trial in ARDS: Peer-Reviewed Publication in Japan
-
2025.07.17
ARTICLE/POSTER
Academic Paper on eNK Cells in “Stem Cell Research and Therapy” Human iPSC-derived NK cells armed with CCL19, CCR2B, high-affinity CD16, IL-15, and NKG2D complex enhance anti-solid tumor activity
-
2025.03.13
ARTICLE/POSTER
ONE-BRIDGE Trial in ARDS: Peer-Reviewed Publication in Japan